Results 141 to 150 of about 46,815 (263)

Forecasting heart failure: Seasonal alignment of heart failure outcomes in New York

ESC Heart Failure, Volume 12, Issue 2, Page 819-831, April 2025.
Abstract Background Seasonal variations have been observed in heart failure (HF) hospitalization. Numerous explanatory mechanisms have been proposed, but no prior studies have examined potential contributors directly. Our objective was to identify specific factors that could contribute to seasonal variability using a large longitudinal dataset of HF ...
Prerna Gupta, Ellen Brinza, Prateeti Khazanie, Pamela N. Peterson, P Michael Ho, David P. Kao   +5 more
wiley   +1 more source

Nuclear Proteome Map of Mouse Heart Chambers. [PDF]

Mol Cell Proteomics
Eslami SS, Rai A, Fang H, Thomas A, Cross J, Donner D, Greening DW.   +6 more
europepmc   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

Downregulation of L-type Ca²⁺ current in patients with atrial fibrillation results from altered channel gating and disruption of membrane microdomains. [PDF]

Heart Rhythm
Balycheva M, Reilly-O'Donnell B, Alvarez-Laviada A, Zhang K, Mazzola M, Sanchez-Alonso JL, Lucarelli C, Medvedev RY, Molina CE, Schobesberger S, Diakonov I, Wright PT, Poulet CE, Bork NI, Trayanova NA, Faggian G, Punjabi P, Nikolaev VO, Glukhov AV, Gorelik J.   +19 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

NOD1 is a key mediator of atrial myopathy in heart failure. [PDF]

Theranostics
Gil-Fernández M, Val-Blasco A, Bueno-Sen A, Cantolla-Pablo P, Galán-Arriola C, Ayaon A, López-Fernández T, Aguilar-Sanchez Y, Lahiri SK, Navarro-García JA, Peinado R, Aroca A, Rubio MÁ, Blázquez JA, Tamayo M, López-Collazo E, Ruiz-Hurtado G, Jorge I, Vázquez J, Prieto P, Smani T, Ordoñez A, Filgueiras-Dama D, Moreno R, Rivero-Santana B, Nuche J, Jalife J, Ibáñez B, Delgado C, Boscá L, Wehrens XHT, Fernández-Velasco M.   +31 more
europepmc   +1 more source

The enzyme systems concerned with acetylcholine synthesis in the atria of the rabbit heart [PDF]

The Journal of Physiology, 1959
openaire   +2 more sources

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Breast cancer, fibrotic signalling, and development of atrial fibrillation. [PDF]

Eur Heart J
Van Wagoner DR.
europepmc   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source